Relief Therapeutics Holding SA

MUN:V6M1 Stock Report

Market Cap: €21.0m

Relief Therapeutics Holding Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Michelle Lock

Chief executive officer

CHF 92.5k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.2yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

CEO

Michelle Lock (55 yo)

less than a year

Tenure

CHF 92,473

Compensation

Ms. Michelle Lock serves as the Interim Chief Executive Officer and Director since November 22, 2023 at Relief Therapeutics Holding AG and served as its Independent Director from January 28, 2022. She serv...

Leadership Team

NamePositionTenureCompensationOwnership
Michelle Lock
Interim CEO & Directorless than a yearCHF 92.47kno data
Jeremy Meinen
CFO & Treasurer1.2yrsno data0.0028%
€ 591.3
Paolo Galfetti
Chief Operating Officer1.3yrsCHF 150.00k0.62%
€ 131.0k

1.2yrs

Average Tenure

55yo

Average Age

Experienced Management: V6M1's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Michelle Lock
Interim CEO & Director2.1yrsCHF 92.47kno data
Raghuram Selvaraju
Chairman of the Board7.8yrsCHF 500.00kno data
Thomas Plitz
Vice-Chairman3.2yrsCHF 150.00k0.010%
€ 2.1k
Patrice Jean
Independent Director2.7yrsCHF 150.00k0.0028%
€ 587.1

2.9yrs

Average Tenure

53.5yo

Average Age

Experienced Board: V6M1's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.